MAY 

- 4 '

K060065-Reply  to FDA  Letter of  March  2, 2006 
10.1.3.2. 

510(k)  Summary  of Safety and  Effectiveness

Information  Capnostream 20and  Capnostream

Confidential

51 0(k)  Summary  of Safety  and  Effectiveness  Information
Capnostream 20 and  Capnostream1 0
(This document is not conrtidential)

DATE  THIS  SUMMARY  WAS  PREPARED

March  20,  2006

SUBMITTERS  NAME  AND  ESTABLISHMENT  ADDRESS:

Oridion Capnography  Inc.

21  Highland  Circle

Needham,  MA  02494-3038

PRODUCT  NAMES
NOTE:  This summary  statement  is for a bundled  submission and  covers the  Capnostreamn2o
and  Capnostreaml 0

CapnostroaM 20

Proprietary:  Capnostream 20
Common:  Two  Parameter  Bedside Monitor

Capnostrearn1 0

Proprietary:  Capnostream1 0
Common:  One  Parameter  Bedside Monitor

ESTABLISHMENT  REGISTRATION  NUMBER

Establishment  Registration  Number:  3003941644

CONTACT  PERSON:

Sanford  Brown,  Regulatory Affairs  Director
Oridion Medical  1987  Ltd.

Har Hotzvim  Science Based  Industrial  Park
P06  45025

91450 Jerusalem,  Israel

Telephone:  +972-2-589-9115

FAX:  +972-2-586-6680

Oridion  Medical  1987 Ltd. 

Page  76

